FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Report a Drug Shortage | Contact Us | FAQ | Background Info | Get Email Alerts | Download Current Drug Shortages

Start Over | Back to Previous Screen

Heparin Sodium and Sodium Chloride 0.9% Injection
Status: Currently in Shortage
»Date first posted: 11/14/2017
»Therapeutic Categories: Hematology

Expand all

B. Braun Medical Inc. (Revised 03/25/2022)

Company Contact Information:
800-227-2862

Presentation	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per FDASIA)
1,000 USP units in 500 mL. Product code P8721 (NDC 0264-9872-10)	Available. On 100% allocation.		Demand increase for the drug

Baxter Healthcare (Revised 05/24/2023)

Company Contact Information:
888-229-0001

Presentation	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per FDASIA)
Heparin Sodium and 0.9% Sodium Chloride Injection, 1,000 units / 500 mL (2 units / mL) in VIAFLEX Plastic Container. Product code AHB0953U (NDC 0338-0424-18)	Available on allocation.	Product code AHB0953U replaces code 2B0953	Manufacturing Delay
Heparin Sodium and 0.9% Sodium Chloride Injection in VIAFLEX Plus Plastic Container: 2,000 USP units in 1000 mL. Product code 2B0944 (NDC 0338-0433-04)	Limited supply on allocation; Recovery late May 2023		Demand increase for the drug
Heparin Sodium and 0.9% Sodium Chloride Injection in VIAFLEX Plus Plastic Container: 1,000 USP units in 500 mL. Product code 2B0953 (NDC 0338-0431-03)	Unavailable		Other

Fresenius Kabi USA, LLC (Revised 05/17/2023)

Company Contact Information:
888-386-1300

Presentation	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per FDASIA)
1,000 Units/500 mL; (2 units/mL); Single dose, freeflex bag; (NDC 63323-519-77)	Available	Check wholesaler for inventory	Other
2,000 Units/1000 mL; (2 units/mL); Single dose, freeflex bag; (NDC 63323-519-10)	2 & 4 month expiry (7/31/2023 & 8/31/2023 expiry) dating available by request.		Other

Hospira, Inc., a Pfizer company (Revised 05/15/2023)

Company Contact Information:
844-646-4398

Presentation	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per FDASIA)
1,000 Units/500 mL (2 Units/mL); Flexible Container (NDC 00409-7620-03)	Limited Supply Available. Next Delivery: May 2023; Estimated Recovery: June 2023	Dear Customer Letter: Availability Update for Multiple Flexible Containers	Demand increase for the drug
2,000 Units/1000 mL (2 Units/mL); Flexible Container (NDC 00409-7620-59)	Limited Supply Available. Next Delivery: May 2023; Estimated Recovery: June 2023	Dear Customer Letter: Availability Update for Multiple Flexible Containers	Demand increase for the drug